Jeffrey Goldberg compensation by year
Spyre Therapeutics Summary Compensation Table · all 2 fiscal years held| Component | FY2022 | FY2023 |
|---|---|---|
| Salary | $54,616 | $248,471 |
| Bonus | $0 | $0 |
| Stock awards | $0 | $0 |
| Option awards | $1,774,952 | $0 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $2,917 | $581,736 |
| Total | $1,832,485 | $830,207 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Spyre Therapeutics, Inc. DEF 14A filed April 1, 2024, accession 0001636282-24-000021, and prior-year filings.
How this page was built: the Spyre Therapeutics, Inc. filed document, accession 0001636282-24-000021. Every figure is read from that document and cited to the page and table it appears in. Filed April 1, 2024.
Spyre Therapeutics’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| Cameron Turtle | Chief Executive Officer | $15,919,545 |
| Jonathan Alspaugh | Former Chief Financial Officer | $8,360,029 |
| Scott Burrows | Chief Financial Officer | $7,551,539 |
| Heidy King-Jones | Chief Legal Officer and Corporate Secretary | $6,588,281 |
| Jeffrey Goldberg · this page | Former President and Chief Executive Officer | $830,207 |
The full Spyre Therapeutics compensation record
free company briefThis page is one person within Spyre Therapeutics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Spyre Therapeutics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Spyre Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.